Can-Fite BioPharma American Depositary Shares
CANF
16 hedge funds and large institutions have $954K invested in Can-Fite BioPharma American Depositary Shares in 2025 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 1 closing their positions.
5,837% more capital inflows, than outflows
Capital inflows: $494K | Capital outflows: $8.31K
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
14% more funds holding
Funds holding: 14 → 16 (+2)
2.74% more ownership
Funds ownership: 7.03% → 9.77% (+2.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$478K |
| 2 |
Bogart Wealth LLC
Mclean,
Virginia
|
+$11.5K |
| 3 |
Morgan Stanley
New York
|
+$2.01K |
| 4 |
BPI
BFC Planning, Inc.
Cedar Rapids,
Iowa
|
+$1.91K |
| 5 |
RhumbLine Advisers
Boston,
Massachusetts
|
+$275 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Securities
New York
|
-$4.14K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$3.22K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$763 |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$189 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6 |
CANF Hedge Fund Activity: Q3 2025 in Review
16 of the 7,657 institutional investors tracked by Wall St. Rank reported a position in Can-Fite BioPharma American Depositary Shares (CANF) for Q3 2025, worth a combined $954K — up 0.42% from $950K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new CANF positions and 1 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Sabby Management, adding an estimated $478K. The largest seller was Two Sigma Securities, cutting an estimated $4.14K.
- 16 institutional investors held Can-Fite BioPharma American Depositary Shares (CANF) as of Q3 2025, up from 14 in Q2 2025.
- Funds reported $954K of Can-Fite BioPharma American Depositary Shares stock for Q3 2025, up 0.42% quarter-over-quarter.
- 3 funds opened new Can-Fite BioPharma American Depositary Shares positions in Q3 2025 and 1 closed out, a net change of +2 holders.
- The largest Can-Fite BioPharma American Depositary Shares buyer in Q3 2025 was Sabby Management, an estimated $478K added.
- The largest Can-Fite BioPharma American Depositary Shares seller in Q3 2025 was Two Sigma Securities, an estimated $4.14K sold.
Based on aggregated 13F filings for Q3 2025.